A method to estimate the potency of the mu-component of an opioid having mixed mu-, and kappa- and/or delta-agonist activities.

Author: FanX T, KitamuraK, LiuX F, OkaT, TaniguchiT

Paper Details 
Original Abstract of the Article :
The SC administration of either typical mu-agonists such as morphine, pethidine, fentanyl and levorphanol or a mixed mu- and delta-agonist like [D-Ala2, D-Leu5]-enkephalin to 10-day-old rats produced loss of righting reflex. Additionally, the loss of righting reflex induced by these opioid agonists ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/BF02245183

データ提供:米国国立医学図書館(NLM)

A New Method for Assessing Opioid Potency: Unveiling the Mu-Component

Opioids are a powerful class of drugs, often used for pain relief, but their complex effects on the body can be challenging to assess. This study introduces a novel method for estimating the potency of opioids, focusing specifically on their activity at mu-receptors, the primary targets for pain relief. The researchers employed a unique in vivo assay, using 10-day-old rats to assess the effects of various opioids on the righting reflex, a measure of neurological function.

Measuring Opioid Potency: A Precise Approach for Assessing Mu-Agonist Activity

The study demonstrates the effectiveness of the in vivo assay for estimating the mu-agonist activity of opioids. The researchers found that the loss of righting reflex induced by various mu-agonists was specifically antagonized by naloxone, a mu-receptor antagonist. Furthermore, the potency of each opioid relative to morphine, a standard reference compound, was consistent with findings from traditional in vitro assays. This method provides a reliable and efficient way to assess the mu-component of opioids with mixed agonist activities.

Navigating the Opioid Landscape: A More Precise Understanding of Drug Effects

This research is like a compass guiding us through the complex desert of opioid pharmacology. The study unveils a new method for precisely measuring the mu-agonist activity of opioids, offering a more accurate understanding of their effects. This tool can prove valuable for developing safer and more effective opioid-based treatments, ensuring a more balanced approach to managing pain.

Dr.Camel's Conclusion

Opioids, like a desert mirage, can offer relief, but their complex effects require careful navigation. This study provides a new compass for understanding the mu-component of opioids, ensuring a more precise understanding of their potency and guiding the development of safer and more effective pain management strategies.

Date :
  1. Date Completed 1995-06-22
  2. Date Revised 2019-07-26
Further Info :

Pubmed ID

7753963

DOI: Digital Object Identifier

10.1007/BF02245183

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.